42-1
42nd Parliament,
1st Session
(December 3, 2015 - September 11, 2019)
Select a different session
Meeting Detail
Televised live on PTN
Thursday, May 18, 2017
10:30 a.m. ET
Location:
Room 2, Victoria Building
Clerk:
Shaila Anwar
(613) 991-0719
Pre-study of Divisions 5, 9, 11, 13, 14 and 16 of Part 4 of Bill C-44 (Budget 2017)
Consideration of a draft report
Witnesses
- Dr. Alan Bernstein, President and Chief Executive Officer(Canadian Institute for Advanced Research )
- Jody Cox, Vice-President, Federal and International Affairs(Canadian Generic Pharmaceutical Association)
- Declan Hamill, Vice-President, Policy, Regulatory, and Legal Affairs(Innovative Medicines Canada)
- Jim Keon, President(Canadian Generic Pharmaceutical Association)
- David K. Lee, Executive Advisor to the Assistant Deputy Minister, Health Products and Food Branch(Health Canada)
- Alison McDermott, Director General, Program Coordination Branch(Innovation, Science and Economic Development Canada)
- Keith McIntosh, Executive Director, Scientific and Regulatory Affairs(Innovative Medicines Canada)
- Naira Minto-Saeed, Director, Strategic Planning and Accountability Division, Resource Management and Operations Directorate, Health Products and Food Branch(Health Canada)
- Ed Morgan, Director General, Policy, Planning and International Affairs Directorate, Health Products and Food Branch(Health Canada)
- Deryck Trehearne, Director General, Resource Management and Operations Directorate, Health Products and Food Branch(Health Canada)
Meeting with interpretation and transcription